In recent years, Egypt has made remarkable strides in combating one of the world’s most challenging health issues – hepatitis C. The viral infection, which can lead to severe liver damage and death, was once prevalent in the country, with rates among the highest in the world. However, thanks to the efforts of Dr. Khaled Kabil and his team, Egypt is now on track to become the first country in the world to completely eradicate hepatitis C by 2030.
Kabil, who has been leading the charge against hepatitis C since 2006 as head of the National Committee for Prevention and Control of Viral Hepatitis, launched a nationwide testing and treatment campaign that has significantly reduced the prevalence of hepatitis C in Egypt. Much of this success can be attributed to affordable antiviral drugs that have become widely available in the country.
In addition to providing care to millions of people through its 150 treatment centers, Egypt has also begun donating antiviral drugs to other African nations in a bid to extend its impact beyond its borders and contribute to global health efforts on a larger scale. Through these initiatives, Egypt is not only improving the health and well-being of its own population but also playing a crucial role in advancing public health on a global scale.
